Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Bite and Sting Relief

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2018
Label revision date
January 18, 2018
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Benzocaine 5 g/100 g
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2018
Label revision date
January 18, 2018
Manufacturer
Better Living
Registration number
part348
NDC root
21130-337
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

This medication is designed to provide temporary relief from pain and itching caused by insect bites. It works by soothing the affected area, helping to alleviate discomfort and irritation. If you've been bitten by an insect and are experiencing these symptoms, this product may help you feel more comfortable.

Uses

If you're dealing with discomfort from insect bites, this medication can help provide temporary relief from both pain and itching. It’s designed to soothe those annoying sensations, allowing you to feel more comfortable. Remember, while it can ease your symptoms, it’s important to follow the recommended guidelines for use.

Dosage and Administration

Before using the medication, make sure to shake the bottle well to ensure the ingredients are mixed properly. If you are an adult or have a child who is 2 years old or older, you can apply the medication to the affected area up to 3 to 4 times a day.

For children under 2 years of age, it’s important to consult a doctor before use to ensure safety and proper care. Always follow these guidelines to help manage the condition effectively.

What to Avoid

It's important to be aware of specific instructions regarding the use of this medication. If you accidentally swallow it, you should seek medical help or contact a Poison Control Center right away. This is crucial for your safety.

Currently, there are no listed contraindications, controlled substance classifications, or concerns about abuse, misuse, or dependence associated with this medication. However, always follow the guidance provided by your healthcare professional to ensure safe use.

Side Effects

When using this product, it's important to follow the directions carefully and avoid contact with your eyes. Remember that it is for external use only and is flammable, so do not use it while smoking or near any heat sources or flames. Additionally, do not puncture or incinerate the container, as it is under pressure and should be stored at temperatures below 120°F.

If your condition worsens, or if your symptoms last more than 7 days or return after clearing up, you should stop using the product and consult a doctor.

Warnings and Precautions

This product is for external use only, so please avoid using it on any internal areas. It is flammable, which means you should not use it while smoking or near any heat sources or flames. When using this product, make sure to follow the directions carefully and keep it away from your eyes. Additionally, do not puncture or burn the container, as it is under pressure. Store it in a cool place, ensuring the temperature does not exceed 120°F.

If your condition worsens, or if your symptoms last longer than 7 days or return after clearing up, stop using the product and consult your doctor. In case of accidental swallowing, seek emergency medical help or contact a Poison Control Center right away.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contacting your local emergency services or going to the nearest hospital is crucial. Always keep the medication packaging with you, as it can help healthcare professionals understand what you've taken. Remember, it's better to be safe and get checked out if you have any concerns about an overdose.

Pregnancy Use

Currently, there is no information available about the use of BITE AND STING RELIEF SIGNATURE CARE - benzocaine 5.00% spray during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions for pregnant individuals have not been established. If you are pregnant or planning to become pregnant, it is important to consult with your healthcare provider before using this product to ensure it is safe for you and your baby.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there is no information available about whether this product is excreted in breast milk or any potential risks to your infant. Always consult with your healthcare provider if you have any concerns or questions about medications while breastfeeding.

Pediatric Use

It's important to keep this medication out of reach of children. If a child accidentally swallows it, seek medical help or contact a Poison Control Center right away.

For children aged 2 years and older, you can apply the medication to the affected area up to 3 to 4 times a day. However, if your child is under 2 years old, you should consult a doctor before use to ensure safety and proper guidance.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

It's always best to discuss your individual situation with your healthcare provider, who can offer personalized advice and ensure that any medications you take are safe and appropriate for your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the information provided does not include specific guidelines for dosage adjustments, special monitoring, or precautions related to your condition. This means that there are no tailored recommendations for how the medication may need to be adjusted or monitored based on your liver function.

Always consult with your healthcare provider for personalized advice and to ensure that any treatment plan is safe and effective for you, especially if you have a history of liver issues. Your doctor can help determine the best approach based on your individual health needs.

Drug Interactions

It's great to know that there are no reported drug interactions or interactions with laboratory tests for this medication. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective, and helps avoid any potential issues.

Always keep your healthcare provider informed about any changes in your health or new medications you start. Open communication is key to managing your health effectively.

Storage and Handling

To ensure the safety and effectiveness of your product, store it in a cool, dry place where the temperature does not exceed 120°F (49°C). This helps maintain its integrity and performance.

When handling the product, please remember not to puncture or incinerate it, as the contents are under pressure. Following these guidelines will help you use the product safely and effectively.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years and older. If the patient is under 2 years old, it's important to consult a doctor before use. There are no additional details regarding laboratory tests, abuse potential, or postmarketing experiences available at this time.

FAQ

What is the purpose of this drug?

This drug is used for the temporary relief of pain and itching associated with insect bites.

How should I use this drug?

Shake well before use. For adults and children 2 years and older, apply to the affected area no more than 3 to 4 times daily. Consult a doctor for children under 2 years of age.

What should I do if I accidentally swallow this drug?

If swallowed, get medical help or contact a Poison Control Center immediately.

Are there any warnings I should be aware of?

Yes, this product is for external use only and is flammable. Avoid contact with eyes, and do not puncture or incinerate the container.

When should I stop using this drug?

Stop use and ask a doctor if the condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days.

Is this drug safe to use during pregnancy or while nursing?

There is no specific information regarding the use of this product during pregnancy or nursing. Consult your doctor for advice.

What should I do if I have a medical condition?

Consult your doctor if you have any medical conditions, especially if you are under 2 years of age, or if you have kidney or liver problems.

How should I store this drug?

Do not store at temperatures above 120°F and do not puncture or incinerate the container.

Packaging Info

Below are the non-prescription pack sizes of Bite and Sting Relief (benzocaine 5.00%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bite and Sting Relief.
Details

Drug Information (PDF)

This file contains official product information for Bite and Sting Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with insect bites. It is intended for use in patients experiencing discomfort due to insect stings or bites.

Dosage and Administration

Healthcare professionals should instruct patients to shake the product well before use. For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. For children under 2 years of age, it is advised to consult a doctor prior to use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, medical assistance should be sought immediately, or contact a Poison Control Center.

Warnings and Precautions

This product is intended for external use only. It is important to note that the product is flammable; therefore, it should not be used while smoking or in proximity to heat or open flames. Users must adhere strictly to the directions provided for use and should avoid any contact with the eyes to prevent irritation or injury.

In the event that the condition worsens or if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days, it is imperative to discontinue use and consult a healthcare professional for further evaluation and guidance.

Emergency medical assistance should be sought immediately if the product is swallowed. In such cases, contacting a Poison Control Center is also recommended to ensure appropriate management of the situation.

Additionally, users should refrain from puncturing or incinerating the container, as it is under pressure. It is crucial to store the product at temperatures not exceeding 120°F to maintain its integrity and safety.

Side Effects

Patients should be aware of several important warnings associated with the use of this product. It is intended for external use only and is classified as flammable; therefore, it should not be used while smoking or near heat or flame. When using this product, patients are advised to follow the directions carefully and to avoid contact with the eyes.

Additionally, the product's contents are under pressure, and it should not be punctured or incinerated. It is crucial to store the product at temperatures not exceeding 120°F to prevent any adverse effects related to pressure buildup.

Patients are instructed to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

There are no documented drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Bite and Sting Relief (benzocaine 5.00%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Bite and Sting Relief.
Details

Pediatric Use

Pediatric patients should be kept out of reach of children. In the event of accidental ingestion, medical assistance or contact with a Poison Control Center is advised immediately.

For pediatric patients aged 2 years and older, the recommended application is to the affected area no more than 3 to 4 times daily. For children under 2 years of age, consultation with a healthcare professional is necessary prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is currently no information available regarding the use of BITE AND STING RELIEF SIGNATURE CARE - benzocaine 5.00% spray during pregnancy. This includes any safety concerns, dosage modifications, or special precautions that may be necessary for pregnant patients. Healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential, as the lack of data precludes a definitive assessment of risks or fetal outcomes. It is advisable to weigh the potential benefits against any unknown risks when recommending this product to pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Continuous assessment and supportive care are critical in managing the patient's condition effectively.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and to consult poison control centers for additional guidance on management strategies.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is crucial to store the product in a manner that maintains its integrity and efficacy.

Storage conditions must not exceed a temperature of 120°F. It is imperative to avoid puncturing or incinerating the container, as the contents are under pressure. Proper handling and storage practices are essential to ensure safety and effectiveness.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged 2 years and older being no more than 3 to 4 times daily. For children under 2 years of age, consultation with a doctor is advised prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Bite and Sting Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Bite and Sting Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.